ATE135566T1 - Arzneimittel zur transmucosalen verabreichung von peptiden - Google Patents

Arzneimittel zur transmucosalen verabreichung von peptiden

Info

Publication number
ATE135566T1
ATE135566T1 AT93917634T AT93917634T ATE135566T1 AT E135566 T1 ATE135566 T1 AT E135566T1 AT 93917634 T AT93917634 T AT 93917634T AT 93917634 T AT93917634 T AT 93917634T AT E135566 T1 ATE135566 T1 AT E135566T1
Authority
AT
Austria
Prior art keywords
peptides
transmucosal administration
medicinal products
administration
liposomic
Prior art date
Application number
AT93917634T
Other languages
English (en)
Inventor
Stefano Poli
Federico Mailland
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of ATE135566T1 publication Critical patent/ATE135566T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT93917634T 1992-07-28 1993-07-23 Arzneimittel zur transmucosalen verabreichung von peptiden ATE135566T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921831A IT1255460B (it) 1992-07-28 1992-07-28 Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive

Publications (1)

Publication Number Publication Date
ATE135566T1 true ATE135566T1 (de) 1996-04-15

Family

ID=11363760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917634T ATE135566T1 (de) 1992-07-28 1993-07-23 Arzneimittel zur transmucosalen verabreichung von peptiden

Country Status (9)

Country Link
EP (1) EP0652744B1 (de)
AT (1) ATE135566T1 (de)
CA (1) CA2141026C (de)
DE (1) DE69301920T2 (de)
DK (1) DK0652744T3 (de)
ES (1) ES2085166T3 (de)
GR (1) GR3019479T3 (de)
IT (1) IT1255460B (de)
WO (1) WO1994003157A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
IT1277338B1 (it) * 1995-07-25 1997-11-10 Poli Ind Chimicia S P A Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
US5843470A (en) 1995-10-06 1998-12-01 Mdv Technologies, Inc. Method and composition for inhibiting post-surgical adhesions
KR970061240A (ko) * 1996-02-26 1997-09-12 이우용 간에서 초회통과 효과를 받는 약물의 직장투여용 조성물
KR970064596A (ko) * 1996-03-21 1997-10-13 이우용 직장투여용 치질치료제 조성물
WO1997034580A1 (en) * 1996-03-21 1997-09-25 Dong Wha Pharmaceutical Industrial Co., Ltd. Suppository composition of the drug which has gastro-intestinal disturbances or undergoes the decomposition by gastric acid
AU723081B2 (en) * 1996-05-09 2000-08-17 Infectio Recherche Inc. Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
US5861174A (en) * 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
JP2001526246A (ja) * 1997-12-23 2001-12-18 アライアンス・ファーマスーティカル・コーポレイション 薬剤送達及び／又は癒着防止のための方法及び組成物
AU6636098A (en) * 1998-03-07 1999-09-20 Dae Woong Pharmaceutical Co., Ltd. Topical composition containing human epidermal growth factor
EP1158957A4 (de) 1999-02-24 2004-12-15 Dong Wha Pharm Ind Co Ltd Flüssige suppositorien-zusammensetzung von diclofenac-natrium
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
AU3903800A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute Gel-microemulsion formulations
JP4822652B2 (ja) * 2000-11-22 2011-11-24 エンド ファーマシューティカルズ インコーポレイテッド 粘膜炎の治療
AU2004216298B2 (en) * 2003-02-28 2009-04-23 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations
WO2007064755A2 (en) 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
GB201116248D0 (en) * 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177223B1 (de) * 1984-09-24 1990-02-28 Michael Mezei Mehrphasige pharmazeutische Zusammensetzung
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
IT1240354B (it) * 1990-03-30 1993-12-07 Poli Ind Chimica Spa Formulazioni liposomiali di farmaci antimicotici,antibatterici e/o antantiflogistici per applicazione locale e vaginale

Also Published As

Publication number Publication date
DE69301920D1 (de) 1996-04-25
DE69301920T2 (de) 1996-08-08
DK0652744T3 (da) 1996-07-08
WO1994003157A1 (en) 1994-02-17
EP0652744A1 (de) 1995-05-17
CA2141026C (en) 2000-04-18
GR3019479T3 (en) 1996-07-31
IT1255460B (it) 1995-11-02
ITMI921831A0 (it) 1992-07-28
CA2141026A1 (en) 1994-02-17
ES2085166T3 (es) 1996-05-16
ITMI921831A1 (it) 1994-01-28
EP0652744B1 (de) 1996-03-20

Similar Documents

Publication Publication Date Title
DE69301920D1 (de) Arzneimittel zur transmucosalen verabreichung von peptiden
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
TW366286B (en) Flavour-masked pharmaceutical compositions
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
MY118371A (en) Tetrahydrolipstatin containing compositions
BG103552A (bg) Терапевтични средства
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ATE116543T1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
SE9703133L (sv) Farmaceutiska beredningar för intranasal administration
DE68917603D1 (de) Verabreichung von arzneimitteln über die lungen.
CO4910114A1 (es) Formulaciones farmaceuticas para suministro de droga soste- nido
FI941771A0 (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
DE69820108D1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
DE69615033D1 (de) Inhalator zur verabreichung von arzneimitteln aus blisterverpackungen
CA2311450A1 (en) Pharmaceutical aerosol compositions
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE69018914D1 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner